期刊文献+

抗凝、抗血小板及溶栓药物的合理应用 被引量:13

The rational application of the anticoagulative,antiplatelet and thrombolytic drugs
下载PDF
导出
摘要 抗凝、抗血小板及溶栓药物是主要针对高危患者预防和治疗血栓形成、栓塞的一类药物,已广泛应用于血管成形和支架植入术。但抗凝、溶栓及抗血小板药物伴随一些不良反应,如出血、血小板减少症等。认识抗凝、溶栓及抗血小板药物的作用机制、适应证并加强监测,有助于我们合理、有效的选用药物,预防和减少不良反应和严重并发症的发生。 Anticoagulative,antiplatelet and thrombolytic drugs play an important role in preventing or treating thrombosis or embolism in some patients with high risk factors.These drugs have been extensively used in patients after angioplasty or stent implantation treatment.However,these drugs are associated with some side effects,such as bleeding,HIT,etc.It is necessary for physicians to recognize the mechanism and indications of these drugs,to closely monitor their side effects and complications,and to use these drugs appropriately and effectively.
作者 王珏 施万印
出处 《介入放射学杂志》 CSCD 北大核心 2011年第1期76-81,共6页 Journal of Interventional Radiology
关键词 抗凝药物 抗血小板药物 溶栓药物 临床应用 anticoaglulative drug antiplatelet drug thrombolytic drug clinical application
  • 相关文献

参考文献5

二级参考文献31

  • 1徐伟,王宗锐.薄荷醇及冰片对磺胺嘧啶和伊文思蓝在脑中分布的影响[J].中药药理与临床,1995,11(6):31-33. 被引量:68
  • 2刘启德,梁美蓉,陈芝喜,冯美蓉,赵萍.冰片对庆大霉素透血脑屏障的影响[J].广州中医学院学报,1994,11(1):37-40. 被引量:105
  • 3王宁生,梁美蓉,刘启德,叶少梅.冰片“佐使则有功”之实验研究[J].中医杂志,1994,35(1):46-47. 被引量:84
  • 4李焰生.缺血性卒中和短暂性脑缺血发作的二级预防指南的新认识[J].国际脑血管病杂志,2006,14(5):321-324. 被引量:31
  • 5BITTL JA, CHAITMAN BR, FEIT F,et al. Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study[J]. Am Heart J, 2001,142(6) :952 -959.
  • 6LINOFF AM, BITTL JA, HARRINGTON RA,et al. Bivalirudin and provisional glycoprotein lib/Ilia blockade compared with heparin and planned glycoprotein lib/Ilia blockade during percutaneous coronary intervention : REPLACE-2 randomized trial [ J ]. JAMA, 2003,289(7 ) :853 - 863.
  • 7GIBSON CM, MORROW DA, MURPHY SA,et al. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention mierovascular dysfunction, isehemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial [ J ]. J Am Coll Cardiol, 2006,47 (12) :2364 - 2373.
  • 8MEDINA RP, FOTO D. The use of bivalirudin to prevent subacute thrombosis during drug-eluting stent implantation[ J]. J Invasive Cardiol, 2004,16 ( 5 ) : 236 - 239.
  • 9WHITE H. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytie therapy for acute myocardial infarction: the HERO-2 randomised trial[ J ]. Lancet, 2001,358 (9296) : 1855 - 1863.
  • 10ALLIE DE, HALL P, SHAMMAS NW,et al. The Angiomax Peripheral Procedure Registry of Vascular Events Trial (APPROVE) : in-hospltal and 30-day results[ J ]. J lnvasive Cardiol, 2004,16 ( 11 ) :651 - 656.

共引文献153

同被引文献123

引证文献13

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部